| RCC | renal cell carcinoma |
| BMI | body mass index |
| OS | overall survival |
| CSS | cancer-specific survival |
| OR | odds ratio |
| HR | hazard ratio |
| CI | confidence interval |
| NSS | nephron sparing surgery |
| RN | radical nephrectomy |
| ECOG scale | Eastern Cooperative Oncology Group scale |
| AR | androgen receptor |
| RFS | recurrence-free survival |
| ERβ | oestrogen receptor-β |
| RR | relative risk |
| SNPs | single-nucleotide polymorphisms |
| CSM | cancer-specific mortality |
| VEGF | vascular endothelial growth factor |
| TKI | tyrosine kinase inhibitor |
| mTOR | mammalian target of rapamycin |
| PD-1 | programmed cell death protein-1 |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
| PFS | progression-free survival |